Lobbyist Insight

Colorado · 2017-2018

HB18-1307

Limit Access To Products With Dextromethorphan

Read HB18-1307 at the Colorado legislature →

14 registered positions on this bill · 14 state a side.

Lobbyist or firmFor clientPositionSession
The Fulcrum Group US LLCAlbertsons SafewaySupporting2017-2018
McGihon, AnneAllergan, Inc.Monitoring2017-2018
REES CONSULTING AND PUBLIC AFFAIRSAllergan, Inc.Monitoring2017-2018
The Howes Group dba Howes WolfCOLORADO RETAIL COUNCILSupporting2017-2018
REES CONSULTING AND PUBLIC AFFAIRSCentura HealthMonitoring2017-2018
Stern, Ellen SteinerChildren's Hospital ColoradoSupporting2017-2018
Colorado Legislative StrategiesConsumer Healthcare Products AssociationSupporting2017-2018
Gutierrez, Carlos I.Consumer Healthcare Products AssociationSupporting2017-2018
Capitol Focus, LLCGLAXOSMITHKLINEMonitoring2017-2018
REES CONSULTING AND PUBLIC AFFAIRSGreenwich Biosciences, IncMonitoring2017-2018
Williams, Alyson BrozovichHealth District of Northern Larimer CountyMonitoring2017-2018
Capitol Focus, LLCJohnson & JohnsonMonitoring2017-2018
Politicalworks, LLCKAISER PERMANENTEMonitoring2017-2018
Mendez, Barkis and AssociatesRxPlus PharmaciesSupporting2017-2018

Positions are as filed. A lobbyist may file more than once as a position changes.